Table 2.
Baseline characteristic | Dose 1 |
Dose 2 |
||||
---|---|---|---|---|---|---|
OR | P-value | 95% CI | OR | P-value | 95% CI | |
Grade 3–4 reactions | ||||||
Female sex (ref.: male) | 6·14 | <0·001 | 3·38–11·14 | 1·68 | <0·001 | 1·49–1·89 |
Age, y | 0·98 | 0·001 | 0·97–0·99 | 0·95 | <0·001 | 0·95–0·96 |
Food allergy (ref.: no) | 3·87 | <0·001 | 1·99–7·52 | 1·61 | 0·05 | 1·01–2·59 |
Grade 3–4 systemic reactions | ||||||
Female sex (ref.: male) | 7·47 | <0·001 | 3·38–16·50 | 1·55 | <0·001 | 1·37–1·75 |
Age, y | 0·98 | 0·01 | 0·97–1·00 | 0·96 | <0·001 | 0·96–0·96 |
Food allergy (ref.: no) | 2·75 | 0·03 | 1·10–6·88 | 1·87 | 0·01 | 1·19–2·94 |
Grade 3–4 local reactions | ||||||
Female sex (ref.: male) | 5·92 | 0·04 | 1·06–33·05 | 1·70 | <0·001 | 1·51–1·91 |
Age, y | 0·99 | 0·18 | 0·97–1·01 | 0·97 | <0·001 | 0·96–0·97 |
Food allergy (ref.: no) | 9·18 | 0·001 | 2·40–35·08 | 0·78 | 0·17 | 0·55–1·11 |
Notes: Covariates to include in the model were chosen using an iterative procedure described in the Methods section.
OR, odds ratio; CI, confidence interval.